Commonwealth Consolidated Regulations

NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS 1960 - REG 37E

         (1)   This regulation deals with how information provided under the price disclosure requirements may be used with the method in regulation 37G for determining the weighted average disclosed price of a listed brand of a pharmaceutical item.

         (2)   To use the method for a brand of a pharmaceutical item (a particular brand ), all the information required under the price disclosure requirements must have been provided for the whole of the data collection period for at least 1 brand (the reported brand ) of a pharmaceutical item that has the same drug and manner of administration as the particular brand.

         (3)   To avoid doubt, the method can be used for determining the weighted average disclosed price of the particular brand, even if:

                (a)    the reported brand is not the particular brand; or

               (b)    the particular brand is the only reported brand.

         (4)   If the information provided by a responsible person under the price disclosure requirements for a reporting period is incomplete, the information may be disregarded in making a determination of the weighted average disclosed price of the brand or every brand of every pharmaceutical item with the same drug and manner of administration.

Note    For reporting periods, see regulations 37J and 37JA.